Literature DB >> 16959874

A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D.

David Piwnica1, Isabelle Fernandez, Nadine Binart, Philippe Touraine, Paul A Kelly, Vincent Goffin.   

Abstract

Cathepsins are lysosomal enzymes that were shown to release the antiangiogenic fragments 16K prolactin (PRL), endostatin, and angiostatin by processing precursors at acidic pH in vitro. However, the physiological relevance of these findings is questionable because the neutral pH of physiological fluids is not compatible with the acidic conditions required for the proteolytic activity of these enzymes. Here we show that cathepsin D secreted from various tissues is able to process PRL into 16K PRL outside the cell. To specifically target extracellular proteolysis, we used tissues from PRL receptor-deficient mice, which are unable to internalize PRL. As assessed by the use of specific inhibitors of proton extruders, we show that the proteolytic activity of cathepsin D requires local acid secretion driven by Na(+)/H(+) exchangers and H(+)/ATPase. Although it is usually assumed that cathepsin-mediated generation of antiangiogenic peptides occurs in the moderately acidic pericellular milieu found in malignant tumors, we propose a new mechanism explaining the extracellular activity of this acidic protease under physiological pH. Our data support the concept that secreted lysosomal enzymes could be involved in the maintenance of angiogenesis dormancy via the generation of active antiangiogenic peptides in nonpathological contexts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959874     DOI: 10.1210/me.2006-0044

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  13 in total

1.  Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis.

Authors:  Jaeok Lee; Syamantak Majumder; Suvro Chatterjee; Kambadur Muralidhar
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

2.  Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.

Authors:  Elena Pedraz-Cuesta; Jacob Fredsted; Helene H Jensen; Annika Bornebusch; Lene N Nejsum; Birthe B Kragelund; Stine F Pedersen
Journal:  Mol Endocrinol       Date:  2016-05-13

3.  Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis.

Authors:  Zan Shen; Chen Yao; Zifeng Wang; Lu Yue; Zheping Fang; Hong Yao; Feng Lin; Hui Zhao; Yuan-Jue Sun; Xiu-Wu Bian; Wenqi Jiang; Xiaomei Wang; Yi Li; Gang Lu; Wai Sang Poon; Hsiang-Fu Kung; Marie Chia-Mi Lin
Journal:  Mol Ther       Date:  2016-03-10       Impact factor: 11.454

Review 4.  Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland.

Authors:  Carmen Clapp; Stéphanie Thebault; Gonzalo Martínez de la Escalera
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

5.  Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.

Authors:  Brian Christensen; Lotte Schack; Eva Kläning; Esben S Sørensen
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

6.  Contribution of individual histidines to the global stability of human prolactin.

Authors:  Camille Keeler; M Cristina Tettamanzi; Syrus Meshack; Michael E Hodsdon
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

7.  Analysis of site-specific histidine protonation in human prolactin.

Authors:  M Cristina Tettamanzi; Camille Keeler; Syrus Meshack; Michael E Hodsdon
Journal:  Biochemistry       Date:  2008-07-25       Impact factor: 3.162

Review 8.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

Review 9.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

10.  Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor.

Authors:  Gaoxiang Ge; Cecilia A Fernández; Marsha A Moses; Daniel S Greenspan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.